The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
In order to become data-driven organizations, healthcare providers need to leverage data standards and information technology.
On-Demand Educational Webinars
Although suppliers and providers may hesitate at a partnership approach, it is possible to collaborate on total cost of ownership. Learn from the…
Podcasts
Learn about how the significant number of clinical alarms have a numbing effect on nursing staff, to the point that patient safety is in jeopardy.
On-Demand Educational Webinars
Supply chain leaders are being charged with mission-critical tasks that require C-suite level engagement and buy-in. In this webinar, we discuss how…
On-Demand Educational Webinars
Resiliency in the operating room is imperative in today’s health care climate. A well-functioning OR has the potential to increase the number of…
Podcasts
As UDI capture and exchange becomes more prevalent across the healthcare ecosystem and as implantable device information is linked to patient outco